• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

Recent Advances in the Study of 2-Methyl-2-(5-nitropyridin-2-yl)propanenitrile (CAS: 1256633-31-4)

The compound 2-Methyl-2-(5-nitropyridin-2-yl)propanenitrile (CAS: 1256633-31-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This nitropyridine derivative has shown promising potential in various applications, particularly in drug discovery and development. Recent studies have focused on its synthesis, physicochemical properties, and biological activities, shedding light on its mechanism of action and therapeutic possibilities.

One of the key breakthroughs in the study of this compound is its role as a versatile intermediate in the synthesis of more complex pharmaceutical agents. Researchers have developed novel synthetic routes to produce 2-Methyl-2-(5-nitropyridin-2-yl)propanenitrile with high yield and purity, which is crucial for its application in medicinal chemistry. The compound's unique structure, featuring both a nitropyridine moiety and a nitrile group, makes it particularly interesting for further chemical modifications.

Recent pharmacological investigations have revealed that 2-Methyl-2-(5-nitropyridin-2-yl)propanenitrile exhibits interesting biological activities. Preliminary studies suggest potential inhibitory effects on certain enzymes involved in inflammatory pathways, making it a candidate for the development of anti-inflammatory drugs. Additionally, its interaction with specific protein targets has been characterized through molecular docking studies, providing insights into its binding modes and structure-activity relationships.

The stability and solubility profile of 2-Methyl-2-(5-nitropyridin-2-yl)propanenitrile have been thoroughly investigated in recent months. These studies are particularly important for understanding its pharmacokinetic properties and potential formulation challenges. Researchers have employed advanced analytical techniques, including HPLC-MS and NMR spectroscopy, to characterize the compound's behavior under various physiological conditions.

Looking forward, the current research trajectory suggests several promising directions for 2-Methyl-2-(5-nitropyridin-2-yl)propanenitrile. Ongoing studies are exploring its potential as a scaffold for developing novel kinase inhibitors and its application in targeted drug delivery systems. The compound's unique chemical properties continue to make it a valuable subject of investigation in both academic and industrial research settings.

• 131941-21-4(2-Isopropyl-5-nitropyridine)
• 123846-66-2(2-(5-nitro-2-pyridyl)acetonitrile)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)